http://rdf.ncbi.nlm.nih.gov/pubchem/reference/15364000

Outgoing Links

Predicate Object
contentType Journal Article|Randomized Controlled Trial|Research Support, Non-U.S. Gov't
endingPage 752
issn 1879-0844
1388-9842
issueIdentifier 7
pageRange 746-752
publicationName European Journal of Heart Failure
startingPage 746
bibliographicCitation Gupta S, Waywell C, Gandhi N, Clayton N, Keevil B, Clark AL, Ng LL, Brooks N, Neyses L. The effects of adding torasemide to standard therapy on peak oxygen consumption, natriuretic peptides, and quality of life in patients with compensated left ventricular systolic dysfunction. Eur J Heart Fail. 2010 Jul;12(7):746–52. doi: 10.1093/eurjhf/hfq090. PMID: 20525705.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2c82566e79b3020c5c8ac43a091e1b1d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_78cdfe291215b302f8147001d7760dae
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_43c7601064563b5627573710410c4512
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_badb730637822643b81097b88830dd1b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ee20dc3878058584523e459d5e089ffb
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_32ac8301fb887623cd87be82f7a812b4
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d43fa56a3146d15d13a0cda0f2c78ff6
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_71ef1e0296a1d25007d4c4d9c11e81f7
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_655ab33f1d21c2c9cdf40f5f6dc05bbf
date 201007
identifier https://doi.org/10.1093/eurjhf/hfq090
https://pubmed.ncbi.nlm.nih.gov/20525705
isPartOf https://portal.issn.org/resource/ISSN/1388-9842
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21509
https://portal.issn.org/resource/ISSN/1879-0844
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title The effects of adding torasemide to standard therapy on peak oxygen consumption, natriuretic peptides, and quality of life in patients with compensated left ventricular systolic dysfunction
discusses http://id.nlm.nih.gov/mesh/M0020790
http://id.nlm.nih.gov/mesh/M0029829
http://id.nlm.nih.gov/mesh/M0086132
http://id.nlm.nih.gov/mesh/M0018776
http://id.nlm.nih.gov/mesh/M0006624
http://id.nlm.nih.gov/mesh/M0284850
http://id.nlm.nih.gov/mesh/M0016224
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D013449Q000627
http://id.nlm.nih.gov/mesh/D020097Q000097
http://id.nlm.nih.gov/mesh/D010101Q000187
http://id.nlm.nih.gov/mesh/D018487Q000188
http://id.nlm.nih.gov/mesh/D010446Q000097
http://id.nlm.nih.gov/mesh/D006333Q000188
http://id.nlm.nih.gov/mesh/D004232Q000627
hasSubjectTerm http://id.nlm.nih.gov/mesh/D000368
http://id.nlm.nih.gov/mesh/D012083Q000097
http://id.nlm.nih.gov/mesh/D011379
http://id.nlm.nih.gov/mesh/D018592
http://id.nlm.nih.gov/mesh/D013449Q000008
http://id.nlm.nih.gov/mesh/D011788
http://id.nlm.nih.gov/mesh/D001794Q000187
http://id.nlm.nih.gov/mesh/D000077786
http://id.nlm.nih.gov/mesh/D005080
http://id.nlm.nih.gov/mesh/D008875
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D013599Q000502
http://id.nlm.nih.gov/mesh/D004311
http://id.nlm.nih.gov/mesh/D000328
http://id.nlm.nih.gov/mesh/D057194
http://id.nlm.nih.gov/mesh/D006339Q000187
http://id.nlm.nih.gov/mesh/D004359
http://id.nlm.nih.gov/mesh/D018487Q000503
http://id.nlm.nih.gov/mesh/D012189
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D006333Q000503
http://id.nlm.nih.gov/mesh/D004232Q000008
http://id.nlm.nih.gov/mesh/D000369
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10274
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID41781
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_360e2ece07507675dced80ba867d6dcd
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7922
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_00559ea764f3549e2a9c714ecd8af73f
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7920
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID977

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128697270

Total number of triples: 73.